Concepts (151)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| GABA Agents | 1 | 2018 | 27 | 0.610 |
Why?
|
| Valproic Acid | 1 | 2018 | 272 | 0.540 |
Why?
|
| Psychotic Disorders | 1 | 2018 | 146 | 0.540 |
Why?
|
| Heart Neoplasms | 1 | 2018 | 209 | 0.520 |
Why?
|
| Carcinoid Tumor | 1 | 2018 | 282 | 0.520 |
Why?
|
| Empathy | 1 | 2016 | 103 | 0.510 |
Why?
|
| Depression | 5 | 2021 | 1733 | 0.490 |
Why?
|
| Oncologists | 1 | 2016 | 136 | 0.470 |
Why?
|
| Pastoral Care | 2 | 2012 | 6 | 0.420 |
Why?
|
| Chaplaincy Service, Hospital | 1 | 2012 | 4 | 0.410 |
Why?
|
| Professional Role | 1 | 2012 | 75 | 0.380 |
Why?
|
| Hallucinations | 1 | 2010 | 34 | 0.360 |
Why?
|
| Meningeal Carcinomatosis | 1 | 2010 | 33 | 0.360 |
Why?
|
| Interdisciplinary Communication | 1 | 2012 | 273 | 0.350 |
Why?
|
| Psychiatry | 1 | 2012 | 270 | 0.310 |
Why?
|
| Vision Disorders | 1 | 2010 | 242 | 0.310 |
Why?
|
| Cognition Disorders | 3 | 2007 | 762 | 0.260 |
Why?
|
| Neoplasms | 7 | 2021 | 15949 | 0.240 |
Why?
|
| Antidepressive Agents | 2 | 2005 | 334 | 0.230 |
Why?
|
| Mental Disorders | 1 | 2012 | 878 | 0.230 |
Why?
|
| Mood Disorders | 1 | 2005 | 163 | 0.230 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2010 | 1068 | 0.230 |
Why?
|
| Interferons | 1 | 2005 | 297 | 0.230 |
Why?
|
| Delirium | 2 | 2016 | 208 | 0.220 |
Why?
|
| Postoperative Complications | 1 | 2018 | 5674 | 0.210 |
Why?
|
| Psycho-Oncology | 1 | 2021 | 6 | 0.200 |
Why?
|
| Anxiety | 4 | 2021 | 1245 | 0.180 |
Why?
|
| Stress, Psychological | 4 | 2013 | 1038 | 0.180 |
Why?
|
| Depressive Disorder, Major | 2 | 2017 | 439 | 0.170 |
Why?
|
| Symptom Assessment | 1 | 2021 | 271 | 0.160 |
Why?
|
| Emergency Service, Hospital | 3 | 2016 | 1257 | 0.150 |
Why?
|
| Pain Management | 1 | 2003 | 716 | 0.140 |
Why?
|
| Anxiety Disorders | 1 | 2021 | 735 | 0.130 |
Why?
|
| Depressive Disorder | 2 | 2017 | 567 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2017 | 907 | 0.110 |
Why?
|
| Fear | 2 | 2012 | 259 | 0.110 |
Why?
|
| Ovarian Neoplasms | 3 | 2017 | 4809 | 0.110 |
Why?
|
| Clergy | 1 | 2012 | 7 | 0.100 |
Why?
|
| Resuscitation Orders | 1 | 1992 | 70 | 0.100 |
Why?
|
| Religion and Medicine | 1 | 2012 | 46 | 0.100 |
Why?
|
| Common Bile Duct Neoplasms | 1 | 2012 | 152 | 0.090 |
Why?
|
| Ampulla of Vater | 1 | 2012 | 160 | 0.090 |
Why?
|
| Humans | 26 | 2021 | 270713 | 0.090 |
Why?
|
| Quetiapine Fumarate | 1 | 2010 | 16 | 0.090 |
Why?
|
| Dibenzothiazepines | 1 | 2010 | 13 | 0.090 |
Why?
|
| Spirituality | 1 | 2012 | 129 | 0.090 |
Why?
|
| Interferon-alpha | 2 | 2004 | 958 | 0.090 |
Why?
|
| Surveys and Questionnaires | 2 | 2021 | 5923 | 0.090 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 517 | 0.080 |
Why?
|
| Medical Oncology | 2 | 2019 | 1464 | 0.080 |
Why?
|
| Attitude to Death | 1 | 2009 | 102 | 0.080 |
Why?
|
| Antipsychotic Agents | 2 | 2010 | 429 | 0.080 |
Why?
|
| Fatal Outcome | 1 | 2010 | 818 | 0.080 |
Why?
|
| Pancreatectomy | 1 | 2012 | 690 | 0.070 |
Why?
|
| Hyperparathyroidism | 1 | 2007 | 101 | 0.070 |
Why?
|
| Syndrome | 1 | 2010 | 1409 | 0.070 |
Why?
|
| Oropharyngeal Neoplasms | 1 | 2016 | 1162 | 0.070 |
Why?
|
| Survivors | 1 | 2012 | 1021 | 0.070 |
Why?
|
| Middle Aged | 12 | 2018 | 90533 | 0.070 |
Why?
|
| Motivation | 1 | 2009 | 515 | 0.070 |
Why?
|
| Parathyroid Neoplasms | 1 | 2007 | 189 | 0.060 |
Why?
|
| Central Nervous System Stimulants | 1 | 2005 | 191 | 0.060 |
Why?
|
| Psychotherapeutic Processes | 1 | 2003 | 5 | 0.060 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 2004 | 2636 | 0.050 |
Why?
|
| Adenoma | 1 | 2007 | 738 | 0.050 |
Why?
|
| Comorbidity | 3 | 2016 | 2393 | 0.050 |
Why?
|
| Female | 13 | 2019 | 148885 | 0.050 |
Why?
|
| Drug Therapy, Combination | 2 | 2004 | 2343 | 0.050 |
Why?
|
| Tomography, Emission-Computed | 4 | 1996 | 334 | 0.050 |
Why?
|
| Retrospective Studies | 2 | 2021 | 39959 | 0.040 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 2219 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2018 | 33847 | 0.040 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2016 | 5604 | 0.040 |
Why?
|
| Risk Factors | 3 | 2016 | 17861 | 0.040 |
Why?
|
| United States | 2 | 2013 | 15828 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2016 | 13419 | 0.040 |
Why?
|
| Social Support | 3 | 2009 | 585 | 0.040 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2012 | 10404 | 0.030 |
Why?
|
| Marijuana Abuse | 1 | 1996 | 68 | 0.030 |
Why?
|
| Male | 9 | 2019 | 128479 | 0.030 |
Why?
|
| Antisocial Personality Disorder | 1 | 1995 | 64 | 0.030 |
Why?
|
| Violence | 1 | 1995 | 124 | 0.030 |
Why?
|
| Pain | 1 | 2003 | 1701 | 0.030 |
Why?
|
| Pancreatic Neoplasms | 1 | 2012 | 5258 | 0.030 |
Why?
|
| Patient Isolation | 1 | 1994 | 25 | 0.030 |
Why?
|
| Adult | 10 | 2016 | 82041 | 0.030 |
Why?
|
| Aged, 80 and over | 4 | 2016 | 31116 | 0.030 |
Why?
|
| Aged | 6 | 2016 | 73613 | 0.030 |
Why?
|
| Affect | 1 | 1994 | 306 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2016 | 636 | 0.030 |
Why?
|
| Cerebral Cortex | 1 | 1995 | 623 | 0.020 |
Why?
|
| Cross-Sectional Studies | 2 | 2012 | 4494 | 0.020 |
Why?
|
| Blood Glucose | 1 | 1995 | 1254 | 0.020 |
Why?
|
| Young Adult | 3 | 2016 | 22243 | 0.020 |
Why?
|
| Brain | 2 | 1996 | 4202 | 0.020 |
Why?
|
| Patient Participation | 1 | 1992 | 454 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 1994 | 1754 | 0.020 |
Why?
|
| Cognition | 1 | 1994 | 969 | 0.020 |
Why?
|
| Heroin Dependence | 1 | 1988 | 60 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2016 | 4007 | 0.020 |
Why?
|
| Papillomavirus Infections | 1 | 2016 | 999 | 0.020 |
Why?
|
| Recurrence | 1 | 2016 | 4878 | 0.020 |
Why?
|
| Family Therapy | 1 | 2007 | 40 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 2549 | 0.020 |
Why?
|
| Religion | 1 | 2007 | 95 | 0.020 |
Why?
|
| Prognosis | 2 | 2016 | 22528 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 6257 | 0.020 |
Why?
|
| Cocaine | 1 | 1988 | 243 | 0.020 |
Why?
|
| Parathyroidectomy | 1 | 2007 | 211 | 0.020 |
Why?
|
| Analysis of Variance | 2 | 2004 | 2315 | 0.020 |
Why?
|
| Frontal Lobe | 2 | 1996 | 169 | 0.020 |
Why?
|
| Quality of Life | 2 | 2010 | 4810 | 0.020 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 1988 | 257 | 0.020 |
Why?
|
| Triage | 1 | 2007 | 252 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2013 | 5099 | 0.010 |
Why?
|
| Personality Disorders | 1 | 2007 | 165 | 0.010 |
Why?
|
| Brain Diseases | 1 | 1988 | 411 | 0.010 |
Why?
|
| Behavior Therapy | 1 | 2007 | 302 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2016 | 9053 | 0.010 |
Why?
|
| Counseling | 1 | 2007 | 380 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2013 | 2395 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1988 | 546 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2013 | 3841 | 0.010 |
Why?
|
| Neoadjuvant Therapy | 1 | 2016 | 5246 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2013 | 9281 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2004 | 982 | 0.010 |
Why?
|
| Mass Screening | 1 | 2009 | 1547 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2013 | 9463 | 0.010 |
Why?
|
| Age Factors | 1 | 2009 | 5441 | 0.010 |
Why?
|
| Survival Rate | 1 | 2012 | 12530 | 0.010 |
Why?
|
| Disease Progression | 1 | 2009 | 6881 | 0.010 |
Why?
|
| Palliative Care | 1 | 2009 | 2176 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 15275 | 0.010 |
Why?
|
| Paleopathology | 1 | 1996 | 2 | 0.010 |
Why?
|
| Psychomotor Disorders | 1 | 1996 | 33 | 0.010 |
Why?
|
| Dronabinol | 1 | 1996 | 41 | 0.010 |
Why?
|
| Basal Ganglia | 1 | 1996 | 62 | 0.010 |
Why?
|
| Deoxyglucose | 1 | 1995 | 119 | 0.010 |
Why?
|
| Environment, Controlled | 1 | 1994 | 22 | 0.010 |
Why?
|
| Temporal Lobe | 1 | 1995 | 190 | 0.010 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 14033 | 0.010 |
Why?
|
| Internal-External Control | 1 | 1994 | 110 | 0.010 |
Why?
|
| Reference Values | 1 | 1995 | 1127 | 0.010 |
Why?
|
| Psychological Tests | 1 | 1994 | 137 | 0.010 |
Why?
|
| Cerebellum | 1 | 1996 | 467 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1996 | 1824 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 1995 | 1260 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 1995 | 988 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1988 | 154 | 0.000 |
Why?
|
| Radiography | 1 | 1988 | 1994 | 0.000 |
Why?
|
| Magnetic Resonance Imaging | 2 | 1988 | 7916 | 0.000 |
Why?
|